ENVALITH
クオールホールディングス株式会社 logo

Qol Holdings Co., Ltd.

3034Prime MarketRetail Trade

クオールホールディングス株式会社 logo
Qol Holdings Co., Ltd.3034
Reference Indicators

Market Cap

817¥100M

P/E (Forecast)

P/B

1.4x

Dividend Yield (Forecast)

2.57%

ROE

12.9%

EV/EBITDA

4.0x
Financial Summary
Unit: ¥M
Item
2022Mar 2022
2023Mar 2023
2024Mar 2024
2025Mar 2025
2026Mar 2026
Net Sales
166,199170,036180,052263,972290,772
Cost of Sales
143,035146,531156,802224,916249,870
Gross Profit
23,16323,50423,24939,05640,902
SG&A Expenses
13,30814,00914,92525,59126,090
Operating Income
9,8559,4958,32413,46514,811
Non-operating Income
4138361,177784754
Non-operating Expenses
173233245418687
Ordinary Income
10,09410,0989,25613,83114,879
Extraordinary Income
74810138376
Extraordinary Losses
4815224971,374575
Pre-tax Income
9,6879,5848,86012,84014,380
Income Taxes
4,1923,9253,9795,3635,907
Net Income
5,4895,6564,8805,1647,408
EBITDA
14,58814,37913,56521,82524,623
Gross Margin
13.9%13.8%12.9%14.8%14.1%
Operating Margin
5.9%5.6%4.6%5.1%5.1%
ROA
5.7%5.6%4.1%3.2%4.7%
ROE
12.9%12.2%9.6%9.4%12.9%
Segment Performance
Unit: ¥M
2026
SegmentNet SalesOperating IncomeOperating Margin
保険薬局事業177,4619,7305.5%
BPO事業14,3001,89813.3%
製薬事業99,0106,9607.0%
薬局事業000.0%